KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Asset Writedowns and Impairment: 2009-2025

Historic Asset Writedowns and Impairment for Synopsys (SNPS) over the last 13 years, with Jul 2025 value amounting to $7.6 million.

  • Synopsys' Asset Writedowns and Impairment rose 61.80% to $7.6 million in Q3 2025 from the same period last year, while for Jul 2025 it was $28.6 million, marking a year-over-year increase of 25.98%. This contributed to the annual value of $19.7 million for FY2024, which is 1.04% down from last year.
  • As of Q3 2025, Synopsys' Asset Writedowns and Impairment stood at $7.6 million, which was up 26.54% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Synopsys' Asset Writedowns and Impairment ranged from a high of $9.9 million in Q1 2025 and a low of -$9.8 million during Q2 2022.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $5.8 million (2023), whereas its average is $5.7 million.
  • As far as peak fluctuations go, Synopsys' Asset Writedowns and Impairment plummeted by 480.50% in 2022, and later surged by 669.49% in 2023.
  • Quarterly analysis of 5 years shows Synopsys' Asset Writedowns and Impairment stood at $4.7 million in 2021, then crashed by 77.90% to $1.0 million in 2022, then spiked by 669.49% to $8.0 million in 2023, then tumbled by 37.11% to $5.0 million in 2024, then spiked by 61.80% to $7.6 million in 2025.
  • Its Asset Writedowns and Impairment stands at $7.6 million for Q3 2025, versus $6.0 million for Q2 2025 and $9.9 million for Q1 2025.